Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04831684 · ClinicalTrials.gov registry record · Phase 1
Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 79
- Enrollment target
NCT04831684 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 79 participants.
The verdict
NCT04831684, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 79 participants
- Enrollment target
Study Summary
This study evaluates the effects of the medication GET73 among non-treatment-seeking individuals who regularly drink alcohol. Participants in the study will take GET73 or placebo for an 8-day study. There are 4 study visits including 2 MRI scans.
Interventions
- DRUG Placebo
- DRUG GET73
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2025-12-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04831684
The ClinicalTrials.gov registry entry for NCT04831684 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04831684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04831684 about?
NCT04831684 is a clinical study titled "Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes". This study evaluates the effects of the medication GET73 among non-treatment-seeking individuals who regularly drink alcohol. Participants in the study will take GET73 or placebo for an 8-day study. There are 4 study visits including 2 MRI scans.
What is the current status of trial NCT04831684?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 79 participants. The study started on 2021-09-15. Estimated completion is 2025-12-29.
What interventions are being tested in trial NCT04831684?
The interventions under investigation include: Placebo (DRUG), GET73 (DRUG).
Who is sponsoring clinical trial NCT04831684?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.